DIVI'S Laboratories Ltd. announced unaudited standalone earnings results for the third quarter and year to date ended December 31, 2011. For the quarter, the company reported net sales of INR 4,146.8 million against INR 3,100.5 million a year ago. Profit from operations before other income, interest and exceptional items was INR 1,349.0 million against INR 1,099.6 million a year ago. Profit from ordinary activities before tax was INR 1,604.0 million against INR 1,164.9 million a year ago. Net profit for the period was INR 1,225.5 million against INR 1,015.7 million a year ago. Diluted earnings per share before and after extraordinary items were INR 9.24 against INR 7.67 a year ago. For the year to date period, the company reported net sales of INR 11,273.1 million against INR 8,259.0 million a year ago. Profit from operations before other income, interest and exceptional items was INR 3,632.0 million against INR 2,729.1 million a year ago. Profit from ordinary activities before tax was INR 4,234.9 million against INR 2,910.7 million a year ago. Net profit for the period was INR 3,311.9 million against INR 2,608.2 million a year ago. Diluted earnings per share before and after extraordinary items were INR 24.97 against INR 19.70 a year ago.